Acadia Pharmaceuticals Ownership | Who Owns Acadia Pharmaceuticals?
Acadia Pharmaceuticals Ownership Summary
Acadia Pharmaceuticals is owned by 97.08% institutional investors, 0.33% insiders, and 2.59% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 25.17% of ACAD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.50% of its assets in Acadia Pharmaceuticals shares.
ACAD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Acadia Pharmaceuticals | 97.08% | 0.33% | 2.59% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 42.91M | 25.17% | $1.09B |
| Blackrock funding, inc. /de | 22.95M | 13.37% | $462.39M |
| Vanguard group | 15.15M | 8.98% | $404.76M |
| Blackrock | 12.06M | 7.32% | $196.01M |
| Vanguard portfolio management | 9.46M | 5.51% | $190.56M |
| State street | 7.65M | 4.46% | $154.17M |
| Rtw investments, lp | 7.14M | 4.19% | $180.76M |
| Vanguard capital management | 5.79M | 3.37% | $116.68M |
| Geode capital management | 3.37M | 1.97% | $67.97M |
| Dimensional fund advisors lp | 3.37M | 1.96% | $67.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Baker bros. advisors lp | 42.91M | 5.44% | $1.09B |
| Verdad advisers, lp | 82.63K | 2.00% | $2.09M |
| Birchview capital, lp | 171.00K | 1.99% | $3.45M |
| Rtw investments, lp | 7.14M | 1.54% | $180.76M |
| Braidwell lp | 1.65M | 1.54% | $41.65M |
| Nan fung group | 102.98K | 1.39% | $2.08M |
| Sphera funds management | 356.53K | 1.18% | $9.02M |
| Frazier life sciences management | 1.44M | 0.79% | $36.39M |
| Rice hall james & associates | 618.89K | 0.76% | $15.66M |
| Tfg asset management gp | 167.88K | 0.67% | $4.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 1.62M | 0.00% | 1.62M |
| Citadel advisors | 2.18M | 0.01% | 1.56M |
| Goldman sachs group | 2.58M | 0.01% | 1.02M |
| D. e. shaw | 1.70M | 0.02% | 968.10K |
| Vanguard portfolio management | 9.46M | 0.01% | 618.67K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Palo alto investors lp | - | - | -2.87M |
| Pictet asset management sa | 343.09K | 0.01% | -1.64M |
| State street | 7.65M | 0.00% | -1.43M |
| Ecor1 capital | - | - | -1.35M |
| Sixth street partners management company | - | - | -1.21M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.62M | 0.00% | 1.62M | $41.07M |
| Alyeska investment group | 310.29K | 0.02% | 310.29K | $7.85M |
| Schonfeld strategic advisors | 284.16K | 0.03% | 284.16K | $7.19M |
| Orbimed advisors | 137.00K | 0.06% | 137.00K | $3.47M |
| Longaeva partners | 117.32K | 0.06% | 117.32K | $2.97M |
Sold Out
| Holder | Change |
|---|---|
| Curio wealth | -1.00 |
| Dunhill financial | -2.00 |
| Corecap advisors | -4.00 |
| Coppell advisory solutions | -4.00 |
| Wealthcollab | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 371 | 1.64% | 166,589,426 | -1.95% | 97 | 0.99% | 216 | 17.39% | 91 | -18.75% |
| Jun 30, 2026 | 359 | 0.56% | 166,753,651 | 1.22% | 97 | 1.03% | 182 | 13.75% | 108 | -16.92% |
| Mar 31, 2026 | 285 | -18.10% | 93,214,952 | -43.97% | 55 | 0.57% | 127 | -25.73% | 102 | -15.70% |
| Dec 31, 2025 | 107 | -69.69% | 24,070,676 | -85.64% | 14 | 0.14% | 52 | -72.92% | 38 | -64.15% |
| Sep 30, 2025 | 134 | -59.02% | 29,202,139 | -82.81% | 17 | 0.17% | 67 | -54.73% | 41 | -66.94% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7.77M | 4.50% | -8.15K |
| Vanguard MStar Total Stk Mkt Idx Invest | 4.10M | 2.38% | 15.32K |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.08M | 2.38% | 18.29K |
| Vanguard Total Stock Mkt Idx Inv | 4.08M | 2.38% | 18.29K |
| Vanguard US Total Market Shares ETF | 3.89M | 2.33% | 4.42K |
| iShares Russell 2000 ETF | 3.26M | 1.89% | - |
| First Trust NYSE Arca Biotech ETF | 3.01M | 1.77% | - |
| Vanguard Small Cap Index | 2.91M | 1.69% | -48.07K |
| State Street® SPDR® S&P® Biotech ETF | 2.65M | 1.54% | 69.42K |
| Vanguard Small Cap Growth Index Inv | 1.70M | 0.99% | 47.42K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 30, 2026 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $69.34K |
| Aug 05, 2026 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $169.64K |
| Aug 06, 2026 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $145.00K |
| Aug 06, 2026 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $272.60K |
| Jul 30, 2026 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Sell | $1.31K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 1 |
| 2026 Q3 | - | 5 |
| 2026 Q2 | - | 6 |
| 2026 Q1 | - | 10 |
| 2025 Q4 | - | 3 |
ACAD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools